Insider Trading
Slightly above 67% of PIRS Old's investor base is looking to short. The analysis of current outlook of investing in PIRS Old suggests that many traders are alarmed regarding PIRS Old's prospects. PIRS Old's investing sentiment can be driven by a variety of factors including economic data, PIRS Old's earnings reports, geopolitical events, and overall market trends.
PIRS |
Filed transaction by Pieris Pharmaceuticals 10 Percent Owner. Insider Public Trading
Read at macroaxis.com
PIRS Old Fundamental Analysis
We analyze PIRS Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PIRS Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PIRS Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Operating Margin
Operating Margin Comparative Analysis
PIRS Old is currently under evaluation in operating margin category among its peers. Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
PIRS Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PIRS Old stock to make a market-neutral strategy. Peer analysis of PIRS Old could also be used in its relative valuation, which is a method of valuing PIRS Old by comparing valuation metrics with similar companies.
Peers
PIRS Old Related Equities
INZY | Inozyme Pharma | 4.12 | ||||
AGEN | Agenus | 1.83 | ||||
ACHL | Achilles Therapeutics | 0.00 | ||||
CKPT | Checkpoint Therapeutics | 0.49 | ||||
CRVS | Corvus Pharmaceuticals | 1.39 | ||||
ADCT | ADC Therapeutics | 1.82 | ||||
AFMD | Affimed NV | 2.25 | ||||
LPTX | Leap Therapeutics | 2.50 | ||||
CUE | Cue Biopharma | 2.91 | ||||
PDSB | PDS Biotechnology | 3.65 | ||||
TERN | Terns Pharmaceuticals | 5.41 | ||||
MREO | Mereo BioPharma | 5.62 | ||||
ADAP | Adaptimmune Therapeutics | 10.71 | ||||
XFOR | X4 Pharmaceuticals | 13.33 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Consideration for investing in PIRS Stock
If you are still planning to invest in PIRS Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PIRS Old's history and understand the potential risks before investing.
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |